A hundred thousand welcomes to Edinburgh and the European Symposium on Late Complicaons aer Childhood Cancer 2009. The city has a long tradition of innovation in almost all fields of human endeavour and enterprise. It has nurtured some of the world’s leading scientists, doctors, writers, engineers and philosophers. Charles Darwin, James Young Simpson, Alexander Fleming and Thomas Hodgkin all lived and studied in the city and connue to inspire students of the capital’s four universies.
Successful treatment of cancer in young people has improved over the past 40 years with around 80% of our patients surviving five years from diagnosis. Some of the therapies that have contributed to the improvement in survival, however, are now known to have serious consequences for the patient in later life. This conference will explore some of the more common and debilitang long-term complicaons.
Improved survival in childhood cancer has come about through pioneering naonal and internaonal studies of rare childhood cancers. There remains a dearth of large multicentre interventional studies evalutiang therapy to prevent, treat or modify late effects in our young survivors.
Following the inaugural symposium in Sweden two years ago, it is our intention to hold a symposium in Europe every two years, alternating with Dan Green’s late effects meeting in North America, with the aim of inspiring future research and collaborations. This year’s symposium addresses six main areas: Cognition, Psychology and Quality of Life, Endocrinology, Growth and Metabolism, Second Malignancies, Gonads and Ferlity, Cardiac complications and Strategies for Long Term Follow Up. We have received more than 100 excellent poster submissions and have selected for oral presentation twelve studies that we think will stimulate and inspire future research. The scientific committee will award the presgious Stephen Shalet and Giulio D’Angio prizes to the two best oral research presentations at the symposium.